Keyword → RTX

U.S. Business Activity Growth Slows Significantly in February, Signals Economic Softening

New data from S&P Global shows that U.S. business activity expanded at the slowest pace in nearly a year in February, reflecting reduced manufacturing orders and slower services growth. While the economy remains in expansion territory, the slowdown could weigh on sentiment and corporate investment plans if the trend persists, particularly in cyclical sectors tied to industrial production and hiring.

Gold Surges Past $5,044 as U.S. Military Strikes on Iran Seen as Imminent, Oil Markets on Edge

Gold prices surged to $5,044 per ounce on Friday as reports circulated that U.S. national security officials have briefed President Trump that the military is prepared for potential strikes on Iran, sending safe-haven assets sharply higher and pushing silver above $80 per ounce, while defense stocks and energy equities rallied on the prospect of broader Middle East conflict.

Tariff Burden on U.S. Households Hits $1,300 as Corporate Guidance Flags Mounting Trade Policy Headwinds

Tax Foundation analysis confirms that President Trump's cumulative tariff regime now represents the largest U.S. tax increase as a share of GDP since 1993, imposing an average annual burden of $1,300 per household in 2026. With Goldman Sachs estimating American companies and consumers bear over three-quarters of tariff costs, earnings guidance across industrials, consumer discretionary, and healthcare is increasingly reflecting this structural drag on margins and consumer demand.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.

Philips Reports 2025 Results With Margin Expansion and 2026 Outlook Targets

Royal Philips published its full-year 2025 financial results, highlighting accelerated growth, expanding profit margins and robust cash flow. The company also unveiled strategic targets for 2026-2028, emphasizing innovation and operational efficiency across health technology segments.

Market Focus Shifts to Jobs, Inflation and Retail Data as Earnings Calendar Warms

Investors are bracing for a key week of economic data and corporate earnings, with delayed January jobs numbers, CPI inflation, and December retail sales due for release. Major technology and consumer firms are also reporting results, highlighting the intersection of macro indicators and corporate performance. These releases are expected to shape expectations for monetary policy and market direction in coming weeks.